FDA's Cleveland Clinic and Duke Connection
This article was originally published in RPM Report
Steven Nissen (Cleveland Clinic) and Robert Califf (Duke) are well known advisers to FDA: outside experts the agency turns to on thorny issues -- especially involving cardiovascular risks. What is less recognized is the prominence of the institutions that Nissen and Califf represent and their impact on the FDA advisory committee process. The agency currently has a dozen advisory committee members from the Cleveland Clinic and Duke.
You may also be interested in...
Former FDA Commissioner David Kessler has a few ideas about the kind of person President-elect Barack Obama should pick to succeed Andrew von Eschenbach at FDA after he takes office Jan. 20
Speculation about the next FDA head is well under way, but before it gets out of hand, here are five rules of thumb to keep in mind.
Steve Nissen has been getting the most attention, but there are plenty of other possibilities. Here are some of the names we’ve heard.